Feature Story
New Blood Test Detects Early-Stage Ovarian Cancer With 90 Percent Accuracy
THURSDAY, November 19, 2015 (International Business Times) — Most of the times, ovarian cancer is difficult to predict until it spreads to the other parts of the body. Achieving a breakthrough in the field of cancer diagnosis, researchers at the Georgia Institute of Technology have figured out a way to diagnose ovarian cancer when it is at its early stage, that too with a striking accuracy.
The research team said that studying blood serum compounds of different molecular weights establishes a biomarker that can be used as a highly effective tool to screen early-stage ovarian cancer.
You might have also missed…
Preventable Colon Cancer Deaths Cost The Economy $6.4 Billion
Nov 13, NPR
U.S. Smoking Rate Declines, but Poor Remain at Higher Risk
Nov 12, The New York Times
Gene Scan Finds Surprising Mutations in Kids With Cancer
Nov 18, NBC News
Pigeons, the next great cancer detector?
Nov 19, CNN
